$28.58
-1.32 (-4.41%)
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Price Target
Analyst Price Target
+113.2% upside
Low Target
$43.15
Average Target
$60.94
High Target
$94.48
Current Price
$28.58
Current
$28.58
$28.58
Target
$60.94
$60.94
$43.15
$60.94 avg
$94.48
Scenario Analysis
Bear Case
$43.15
51.0%
Low target
Base Case
$60.94
+113.2%
Avg target
Bull Case
$94.48
+230.6%
High target
Risk/Reward
4.5x
Highly favorable
Price in Context
52-Week High
$45.42
-37.1% from high
52-Week Low
$21.05
+35.8% from low
50-Day SMA
$33.68
-15.1% vs SMA
200-Day SMA
$32.09
-10.9% vs SMA
RSI (14)
63.8
Neutral
Target vs 52W High
$60.94
+34.2% vs high
Next Earnings Report
Nov 9, 2026
2d
until earnings
EPS Est: $-0.75
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -10.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +116.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 35% | $149.45 | -38.1% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -60.7% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -35.8% |